Dr. Reddy's Laboratories
RDY
#1853
Rank
โ‚ฌ9.78 B
Marketcap
11,72ย โ‚ฌ
Share price
0.37%
Change (1 day)
-6.73%
Change (1 year)

Revenue for Dr. Reddy's Laboratories (RDY)

Revenue in 2025 (TTM): โ‚ฌ3.43 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current revenue (TTM ) is โ‚ฌ3.40 Billion. a decrease over the revenue in the year 2024 that were of โ‚ฌ3.55 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dr. Reddy's Laboratories from 2002 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ3.36 B-5.32%
2024 โ‚ฌ3.55 B19.8%
2023 โ‚ฌ2.96 B7.22%
2022 โ‚ฌ2.76 B12.04%
2021 โ‚ฌ2.47 B21.08%
2020 โ‚ฌ2.04 B-5.84%
2019 โ‚ฌ2.16 B14.73%
2018 โ‚ฌ1.88 B3.02%
2017 โ‚ฌ1.83 B-9.36%
2016 โ‚ฌ2.02 B-8.51%
2015 โ‚ฌ2.21 B14.28%
2014 โ‚ฌ1.93 B21.38%
2013 โ‚ฌ1.59 B10.12%
2012 โ‚ฌ1.44 B-0.14%
2011 โ‚ฌ1.44 B22.5%
2010 โ‚ฌ1.18 B10.8%
2009 โ‚ฌ1.06 B5.92%
2008 โ‚ฌ1.00 B15.2%
2007 โ‚ฌ0.87 B-7.25%
2006 โ‚ฌ0.94 B116%
2005 โ‚ฌ0.43 B34.6%
2004 โ‚ฌ0.32 B-3.5%
2003 โ‚ฌ0.33 B-3.98%
2002 โ‚ฌ0.35 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚ฌ48.75 B 1,330.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ54.55 B 1,500.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ47.79 B 1,302.16%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
โ‚ฌ38.05 B 1,016.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.94 B 338.59%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel